SCHEMBL3935879

SCHEMBL3935879

CC(C)(C)[Si](OCc1cncc(N=C(c2ccccc2)c2ccccc2)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
GPR132 Q9UNW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3932476 0.76 TACR1 (0.43)
SCHEMBL1630838 0.76 CYP11B1 (0.40)
SCHEMBL1314001 0.72 AGXT (0.42)
SCHEMBL14449078 0.72 HTR1A (0.43) GPR132
SCHEMBL7617913 0.70 LMNA (0.46) GPR132
SCHEMBL29203398 0.70 ACSS2 (0.35)
SCHEMBL30240876 0.70 ACSS2 (0.35)
SCHEMBL31124766 0.70 TSHR (0.35) ESR1ESR2
SCHEMBL31160327 0.70 TOP2A (0.43)
SCHEMBL31226339 0.70 HTR2C (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed
WO-2006067445-A2 CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed